BRUGADA SYNDROME (BRS)
Clinical trials for BRUGADA SYNDROME (BRS) explained in plain language.
Never miss a new study
Get alerted when new BRUGADA SYNDROME (BRS) trials appear
Sign up with your email to follow new studies for BRUGADA SYNDROME (BRS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart rhythm breakthrough? diabetes drug tested for rare syndrome
Disease control Not yet recruitingThis study is testing if a drug called Empagliflozin, commonly used for diabetes, can help control Brugada syndrome, a rare genetic heart condition that can cause dangerous irregular heartbeats. Researchers will give the drug to 10 adult patients for three months to see if it imp…
Matched conditions: BRUGADA SYNDROME (BRS)
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Could cancer treatment trigger a hidden heart risk?
Knowledge-focused Not yet recruitingThis study aims to understand if people with breast or colon cancer develop certain antibodies that might accidentally affect their heart. Researchers will check for these antibodies in the blood of 196 patients over a year. The goal is to gather knowledge, not to test a new trea…
Matched conditions: BRUGADA SYNDROME (BRS)
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC